Oculon Corp., of Cambridge, Mass., appointed Pauliana Hall directorof regulatory affairs and quality assurance.OsteoArthritis Sciences Inc., of Cambridge, Mass., named WilliamCrouse, Gerard Moufflet and Ronald Lennox to the board of directorsand Thomas Sharpe vice president of research and development.Oxford GlycoSystems, of Oxford, England, appointed Stephen Charlesdirector of research and Gordon Holt senior research scientist.Target Therapeutics, of Fremont, Calif., appointed Abhi Acharya vicepresident of regulatory, quality and clinical affairs, Timothy Mills vicepresident of new business development and Kevin Riley vice presidentof worldwide marketing.Titan Pharmaceuticals Inc., of South San Francisco, named thefollowing directors to subsidiary companies: Louis Sullivan to GeneticSciences Inc.; Chong Yoon to Ansan Inc.; and Marvin Jaffe toTheracell Inc.

(c) 1997 American Health Consultants. All rights reserved.